Genenta Science SPA
NASDAQ:GNTA
Genenta Science SPA
Cash from Operating Activities
Genenta Science SPA
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Genenta Science SPA
NASDAQ:GNTA
|
Cash from Operating Activities
-€11.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Philogen SpA
MIL:PHIL
|
Cash from Operating Activities
-€4.8m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ulisse Biomed Spa
MIL:UBM
|
Cash from Operating Activities
-€970.5k
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Genenta Science SPA's Cash from Operating Activities?
Cash from Operating Activities
-11.2m
EUR
Based on the financial report for Dec 31, 2023, Genenta Science SPA's Cash from Operating Activities amounts to -11.2m EUR.
What is Genenta Science SPA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-23%
Over the last year, the Cash from Operating Activities growth was -51%. The average annual Cash from Operating Activities growth rates for Genenta Science SPA have been -23% over the past three years .